Realising the full potential of data-enabled trials in the UK: a call for action
Journal article
LANDRAY M. et al, (2021), BMJ Open
Realising the full potential of data-enabled trials in the UK: a call for action
Journal article
LANDRAY M. et al, (2021), BMJ Open
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
LANDRAY M. et al, (2021), The Lancet
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
LANDRAY M. et al, (2021), The Lancet
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
The RECOVERY Collaborative Group None. et al, (2021)
Author Correction: Potential health and economic impacts of dexamethasone treatment for patients with COVID-19.
Journal article
Águas R. et al, (2021), Nat Commun, 12
Hydroxychloroquine in Hospitalized Patients with Covid-19. Reply.
Journal article
Horby P. et al, (2021), N Engl J Med, 384
Dexamethasone in Hospitalized Patients with Covid-19.
Journal article
RECOVERY Collaborative Group None. et al, (2021), N Engl J Med, 384, 693 - 704
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2021), Lancet, 397, 605 - 612
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial
Journal article
RECOVERY Collaborative Group None. et al, (2021)
Potential health and economic impacts of dexamethasone treatment for patients with COVID-19.
Journal article
Águas R. et al, (2021), Nat Commun, 12
Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
LANDRAY M. et al, (2021), The Lancet
Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study.
Journal article
Morris EJA. et al, (2021), Lancet Gastroenterol Hepatol
Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
Horby P. et al, (2020)
Conventional and Genetic Evidence on the Association between Adiposity and CKD.
Journal article
Zhu P. et al, (2020), J Am Soc Nephrol
Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
RECOVERY Collaborative Group None., (2020), Lancet. 2020;396(10259):1345-52.
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.
Journal article
RECOVERY Collaborative Group None. et al, (2020), N Engl J Med
Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2020), Lancet
CONVENTIONAL AND GENETIC EVIDENCE ON THE ASSOCIATION BETWEEN ADIPOSITY AND CHRONIC KIDNEY DISEASE
Journal article
HERRINGTON W. et al, (2020), Journal of the American Society of Nephrology
Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom.
Journal article
Hopewell JC. et al, (2020), Eur Heart J, 41, 3336 - 3342